BIOLASE, INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Biolase, Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Biolase, Inc Entity Common Stock, Shares Outstanding for the quarter ending August 1, 2024 was 36.6M shares, a 3406% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 36.6M +35.6M +3406% Aug 1, 2024 10-Q 2024-08-08
Q1 2024 32.5M -26.3B Mar 14, 2024 10-K 2024-03-21
Q3 2023 2.3M -4.85M -67.9% Nov 2, 2023 10-Q 2023-11-09
Q2 2023 1.04M -5.81M -84.8% Aug 3, 2023 10-Q 2023-08-10
Q1 2023 26.3B* +26.2B Mar 21, 2023 10-K 2023-03-28
Q3 2022 7.15M -146M -95.3% Nov 3, 2022 10-Q 2022-11-10
Q2 2022 6.85M -144M -95.5% Aug 4, 2022 10-Q 2022-08-11
Q1 2022 154M +4.96M +3.32% Mar 10, 2022 10-K 2022-03-17
Q3 2021 153M +60.3M +64.8% Nov 4, 2021 10-Q 2021-11-10
Q2 2021 151M +59M +64% Aug 5, 2021 10-Q 2021-08-13
Q1 2021 149M +118M +373% Mar 25, 2021 10-K 2021-03-31
Q3 2020 93M +62.1M +201% Nov 10, 2020 10-Q 2020-11-13
Q2 2020 92.2M +70.3M +322% Aug 11, 2020 10-Q 2020-08-14
Q1 2020 31.6M +10.5M +49.5% Mar 20, 2020 10-K 2020-03-30
Q3 2019 30.9M +10.3M +49.8% Nov 6, 2019 10-Q 2019-11-12
Q2 2019 21.9M +1.27M +6.16% Aug 7, 2019 10-Q 2019-08-09
Q1 2019 21.1M -81.2M -79.4% Mar 5, 2019 10-K 2019-03-08
Q3 2018 20.7M -55.4M -72.8% Nov 12, 2018 10-Q 2018-11-14
Q2 2018 20.6M -55.4M -72.9% Aug 6, 2018 10-Q 2018-08-13
Q1 2018 102M +34.8M +51.5% Mar 7, 2018 10-K 2018-03-14
Q3 2017 76M +8.45M +12.5% Oct 27, 2017 10-Q 2017-11-01
Q2 2017 76M +17.7M +30.4% Jul 31, 2017 10-Q 2017-08-07
Q1 2017 67.6M +9.34M +16% Mar 6, 2017 10-K 2017-03-10
Q3 2016 67.6M +9.34M +16% Nov 1, 2016 10-Q 2016-11-08
Q2 2016 58.3M +66.6K +0.12% Jul 29, 2016 10-Q 2016-08-01
Q1 2016 58.2M +74.7K +0.13% Feb 29, 2016 10-K 2016-03-11
Q3 2015 58.2M +14.3M +32.5% Oct 30, 2015 10-Q 2015-11-06
Q2 2015 58.2M +14.3M +32.6% Jul 31, 2015 10-Q 2015-08-07
Q1 2015 58.2M +20.5M +54.6% Apr 27, 2015 10-Q 2015-05-01
Q3 2014 44M +9.1M +26.1% Oct 31, 2014 10-Q 2014-11-07
Q2 2014 43.9M +9.93M +29.2% Aug 1, 2014 10-Q 2014-08-08
Q1 2014 37.6M +6.28M +20% Apr 30, 2014 10-Q 2014-05-12
Q3 2013 34.9M +3.73M +12% Oct 18, 2013 10-Q 2013-11-12
Q2 2013 34M +2.88M +9.25% Jul 22, 2013 10-Q 2013-08-09
Q1 2013 31.3M +795K +2.6% Mar 8, 2013 10-K 2013-03-15
Q3 2012 31.1M +813K +2.68% Nov 2, 2012 10-Q 2012-11-09
Q2 2012 31.1M +1.19M +3.98% Aug 3, 2012 10-Q/A 2012-09-06
Q1 2012 30.5M Mar 9, 2012 10-K 2012-03-13
Q3 2011 30.3M Nov 8, 2011 10-Q 2011-11-10
Q2 2011 29.9M Aug 9, 2011 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.